Filing Details

Accession Number:
0001144204-17-046676
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-05 22:00:31
Reporting Period:
2017-09-01
Accepted Time:
2017-09-05 21:00:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1270073 Intercept Pharmaceuticals Inc ICPT Pharmaceutical Preparations (2834) 223868459
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559570 David Shapiro C/O Intercept Pharmaceuticals, Inc.
10 Hudson Yards, Floor 37
New York NY 10001
Cmo And Evp - Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-01 1,250 $31.90 45,812 No 4 M Direct
Common Stock Disposition 2017-09-01 1,250 $117.43 44,562 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Common Stock Disposition 2017-09-01 1,250 $0.00 1,250 $31.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,031 2023-05-07 No 4 M Direct
Footnotes
  1. The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person.
  2. All shares underlying this option have vested.